Hertz-Picciotto I, Croen LA, Hansen R, et al.: The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 2006, 114:1119–1125.
Abrahams BS, Geschwind DH: Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008, 9:341–355.
Lainhart JE, Ozonoff S, Coon H, et al.: Autism, regression, and the broader autism phenotype. Am J Med Genet 2002, 113:231–237.
Horvath K, Perman JA: Autism and gastrointestinal symptoms. Curr Gastroenterol Rep 2002, 4:251–258.
Porter EM, Bevins CL, Ghosh D, Ganz T: The multifaceted Paneth cell. Cell Mol Life Sci 2002, 59:156–170.
Lee J, Gonzales-Navajas JM, Raz E: The “polarizing-tolerizing” mechanism of intestinal epithelium: its relevance to colonic homeostasis. Semin Immunopathol 2008, 30:3–9.
Lee J, Mo JH, Shen C, et al.: Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 2007, 23:27–31.
White JF: Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 2003, 228:639–649.
D’Eufemia P, Celli M, Finocchiaro R, et al.: Abnormal intestinal permeability in children with autism. Acta Paediatr 1996, 85:1076–1079.
Horvath K, Collins RM, Rabsztyn A, et al.: Secretin improves intestinal permeability in autistic children [abstract]. J Pediatr Gastroenterol Nutr 2000, S31:31.
Robertson MA, Sigalet DL, Holst JJ, et al.: Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study. J Autism Dev Disord 2008, 38:1066–1071.
Dupont C, Heyman M: Food protein-induced enterocolitis syndrome: laboratory perspectives. J Pediatr Gastroenterol Nutr 2000, 30(Suppl):S50–S57.
Heyman M: Gut barrier dysfunction in food allergy. Eur J Gastroenterol Hepatol 2005, 17:1279–1285.
Ventura MT, Polimeno L, Amoruso AC, et al.: Intestinal permeability in patients with adverse reactions to food. Dig Liver Dis 2006, 38:732–736.
Chin AC, Lee WY, Nusrat A, et al.: Neutrophil-mediated activation of epithelial protease-activated receptors-1 and -2 regulates barrier function and transepithelial migration. J Immunol 2008, 181:5702–5710.
Magalhaes JG, Tattoli I, Girardin SE: The intestinal epithelial barrier: how to distinguish between the microbial flora and pathogens. Semin Immunol 2007, 19:106–115.
Rescigno M, Urbano M, Valzasina B, et al.: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2001, 2:361–367.
Chehade M, Mayer L: Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005, 115:3–12; quiz 13.
Man AL, Lodi F, Bertelli E, et al.: Macrophage migration inhibitory factor plays a role in the regulation of microfold (M) cell-mediated transport in the gut. J Immunol 2008, 181:5673–5680.
Mucida D, Park Y, Kim G, et al.: Reciprocal Th17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256–260.
Sun CM, Hall JA, Blank RB, et al.: Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J Exp Med 2007, 204:1775–1785.
Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, et al.: A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 2007, 204:1757–1764.
Burks AW, Laubach S, Jones SM: Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008, 121:1344–1350.
Kelly D, Campbell JI, King TP, et al.: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclearcytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004, 5:104–112.
Sandler RH, Finegold SM, Bolte ER, et al.: Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000, 15:429–435.
Finegold SM, Molitoris D, Song Y, et al.: Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 2002, 35:S6–S16.
Parracho HM, Bingham MO, Gibson GR, McCartney AL: Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005, 54:987–991.
Shultz SR, MacFabe DF, Ossenkopp KP, et al.: Intracerebroventricular injection of propionic acid, an enteric bacterial metabolic end-product, impairs social behavior in the rat: implications for an animal model of autism. Neuropharmacology 2008, 54:901–911.
MacFabe DF, Cain DP, Rodriguez-Capote K, et al.: Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav Brain Res 2007, 176:149–169.
Furlano RI, Anthony A, Day R, et al.: Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr 2001, 138:366–372.
Wakefield AJ, Anthony A, Murch SH, et al.: Enterocolitis in children with developmental disorders. Am J Gastroenterol 2000, 95:2285–2295.
Wakefield AJ, Ashwood P, Limb K, Anthony A: The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. Eur J Gastroenterol Hepatol 2005, 17:827–836.
Ashwood P, Anthony A, Pellicer AA, et al.: Intestinal lymphocyte populations in children with regressive autism: evidence for extensive mucosal immunopathology. J Clin Immunol 2003, 23:504–517.
Torrente F, Ashwood P, Day R, et al.: Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 2002, 7:375–382, 334.
Ashwood P, Wakefield AJ: Immune activation of peripheral blood and mucosal CD3+ lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms. J Neuroimmunol 2006, 173:126–134.
Ashwood P, Anthony A, Torrente F, Wakefield AJ: Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004, 24:664–673.
DeFelice ML, Ruchelli ED, Markowitz JE, et al.: Intestinal cytokines in children with pervasive developmental disorders. Am J Gastroenterol 2003, 98:1777–1782.
Lala S, Ogura Y, Osborne C, et al.: Crohn’s disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 2003, 125:47–57.
Cho JH: The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008, 8:458–466.
Vargas DL, Nascimbene C, Krishnan C, et al.: Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005, 57:67–81.
Pardo CA, Vargas DL, Zimmerman AW: Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 2005, 17:485–495.
Zimmerman AW, Jyonouchi H, Comi AM, et al.: Cerebrospinal fluid and serum markers of inflammation in autism. Pediatr Neurol 2005, 33:195–201.
Pardo CA, Eberhart CG: The neurobiology of autism. Brain Pathol 2007, 17:434–447.
Ashwood P, Kwong C, Hansen R, et al.: Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype?
J Autism Dev Disord 2008, 38:169–175.
Chauhan A, Chauhan V, Brown WT, Cohen I: Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin—the antioxidant proteins. Life Sci 2004, 75:2539–2549.
Deth R, Muratore C, Benzecry J, et al.: How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. Neurotoxicology 2008, 29:190–201.
James SJ, Melnyk S, Jernigan S, et al.: Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:947–956.
Martin-Ruiz CM, Lee M, Perry RH, et al.: Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 2004, 123:81–90.
Ashley-Koch AE, Mei H, Jaworski J, et al.: An analysis paradigm for investigating multi-locus effects in complex disease: examination of three GABA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder. Ann Hum Genet 2006, 70:281–292.
Vincent JB, Horike SI, Choufani S, et al.: An inversion inv(4)(p12–p15.3) in autistic siblings implicates the 4p GABA receptor gene cluster. J Med Genet 2006, 43:429–434.
Thompson WW, Price C, Goodson B, et al.: Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 2007, 357:1281–1292.
Silva MF, Aires CC, Luis PB, et al.: Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J Inherit Metab Dis 2008 Apr 4 (Epub ahead of print).
Gupta S, Aggarwal S, Rashanravan B, Lee T: Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998, 85:106–109.
Molloy CA, Morrow AL, Meinzen-Derr J, et al.: Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006, 172:198–205.
Bakkaloglu B, Anlar B, Anlar FY, et al.: Atopic features in early childhood autism. Eur J Paediatr Neurol 2008, 12:476–479.
Karlsson MR, Rugtveit J, Brandtzaeg P: Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med 2004, 199:1679–1688.
Jyonouchi H, Geng L, Ruby A, et al.: Evaluation of an association between gastrointestinal symptoms and cytokine production against common dietary proteins in children with autism spectrum disorders. J Pediatr 2005, 146:605–610.
Hwang JB, Sohn SM, Kim AS: Prospective follow up-oral food challenge in food protein-induced enterocolitis syndrome. Arch Dis Child 2008 Oct 1 (Epub ahead of print).
Horwitz DA, Zheng SG, Gray JD: Natural and TGF-betainduced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 2008, 29:429–435.
Christison GW, Ivany K: Elimination diets in autism spectrum disorders: any wheat amidst the chaff?
J Dev Behav Pediatr 2006, 27:S162–S171.
Knivsberg AM, Reichelt KL, Hoien T, Nodland M: A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 2002, 5:251–261.
Elder JH, Shankar M, Shuster J, et al.: The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord 2006, 36:413–420.
Cornish E: Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. J Hum Nutr Diet 2002, 15:261–269.
Bolman WM, Richmond JA: A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. J Autism Dev Disord 1999, 29:191–194.
Kern JK, Miller VS, Cauller PL, et al.: Effectiveness of N,Ndimethylglycine in autism and pervasive developmental disorder. J Child Neurol 2001, 16:169–173.
Chapman TM, Plosker GL, Figgitt DP: VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs 2006, 66:1371–1387.
Isolauri E, Salminen S: Probiotics: use in allergic disorders: a Nutrition, Allergy, Mucosal Immunology, and Intestinal Microbiota (NAMI) Research Group Report. J Clin Gastroenterol 2008, 42(Suppl 2):S91–S96.
Savilahti E, Kuitunen M, Vaarala O: Pre and probiotics in the prevention and treatment of food allergy. Curr Opin Allergy Clin Immunol 2008, 8:243–248.